2015 Deep Research Report on Global Biologics and Biosimilars Industry

January 2015 | 170 pages | ID: 2127D118E09EN
QYResearch

Abstracts

2015 Deep Research Report on Global Biologics and Biosimilars Industry is a professional and depth research report on Global Biologics and Biosimilars industry.

For overview analysis, the report introduces Biologics and Biosimilars basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.

For international and China market analysis, the report analyzes Biologics and Biosimilars markets in China and other countries or regions (such as Asia, Europe, North America etc) by presenting research on global products of different types and applications, developments and trends of market, technology, and competitive landscape, and leading suppliers and countries’ 2010-2015 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as production value, customers, application, market position, and company contact information, etc. 2016-2021 forecast on production value for these markets are also included.

For technical data and manufacturing plants analysis, the report analyzes Biologics and Biosimilars leading suppliers on commercial production value, manufacturing plants distribution, R&D Status, technology sources, and raw materials sources.

This report also presents product specification, manufacturing process, and product value etc. Production is separated by regions, technology and applications. Analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals.

In the end, the report includes Biologics and Biosimilars new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis. In conclusion, it is a deep research report on Global Biologics and Biosimilars industry. Here, we express our thanks for the support and assistance from Biologics and Biosimilars industry chain related technical experts and marketing engineers during Research Team’s survey and interviews.

Contents

CHAPTER ONE BIOLOGICS AND BIOSIMILARS INDUSTRY OVERVIEW

1.1 Biologics and Biosimilars Definition
1.2 Biologics and Biosimilars Classification and Application
1.3 Biologics and Biosimilars Industry Chain Structure
1.4 Biologics and Biosimilars Industry Overview
1.5 Biologics and Biosimilars Industry Policy Analysis
1.6 Biologics and Biosimilars Industry News Analysis

CHAPTER TWO BIOLOGICS AND BIOSIMILARS INTERNATIONAL AND CHINA MARKET ANALYSIS

2.1 Biologics and Biosimilars Industry International Market Analysis
  2.1.1 Biologics and Biosimilars International Market Development History
  2.1.2 Biologics and Biosimilars Product and Technology Developments
  2.1.3 Biologics and Biosimilars Competitive Landscape Analysis
  2.1.4 Biologics and Biosimilars International Key Countries Development Status
  2.1.5 Biologics and Biosimilars International Market Development Trend
2.2 Biologics and Biosimilars Industry China Market Analysis
  2.2.1 Biologics and Biosimilars China Market Development History
  2.2.2 Biologics and Biosimilars Product and Technology Developments
  2.2.3 Biologics and Biosimilars Competitive Landscape Analysis

CHAPTER THREE BIOLOGICS AND BIOSIMILARS TECHNICAL DATA ANALYSIS

3.1 2010-2015E Global Key Manufacturers Biologics Revenue Structure Analysis
3.2 2010-2015E Global Key Manufacturers Biosimilars Revenue Structure Analysis

CHAPTER FOUR BIOLOGICS AND BIOSIMILARS PATENT ANALYSIS

4.1 2013 Global Top Ten Biosimilars Products Sales Analysis
4.2 Biological Medicines with Patents about to expire or expired

CHAPTER FIVE BIOLOGICS AND BIOSIMILARS MANUFACTURING PROCESS AND COST STRUCTURE

5.1 Biologics and Biosimilars Product Specifications
5.2 Biologics and Biosimilars Manufacturing Process Analysis
5.3 Biologics and Biosimilars Marketing Process Analysis
5.4 Biologics and Biosimilars Approval Process Analysis
5.5 Biologics and Biosimilars Cost Structure Analysis
5.6 Biologics and Biosimilars Price Analysis

CHAPTER SIX 2010-2015E BIOLOGICS AND BIOSIMILARS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS

6.1 2010-2015E Biologics Industry Overview
6.2 2010-2015E Biosimilars Industry Overview

CHAPTER SEVEN BIOLOGICS AND BIOSIMILAR MAJOR MANUFACTURERS ANALYSIS

Biologics
7.1 Pfizer
  7.1.1 Company Profile
  7.1.2 Sales (Million $) Sales growth rate
  7.1.3 Contact Information
7.2 Roche
  7.2.1 Company Profile
  7.2.2 Sales (Million $) Sales growth rate
  7.2.3 Contact Information
7.3 Amgen
  7.3.1 Company Profile
  7.3.2 Sales (Million $) Sales growth rate
  7.3.3 Contact Information
7.4 AbbVie
  7.4.1 Company Profile
  7.4.2 Sales (Million $) Sales growth rate
  7.4.3 Contact Information
7.5 Sanofi
  7.5.1 Company Profile
  7.5.2 Sales (Million $) Sales growth rate
  7.5.3 Contact Information
7.6 Johnson & Johnson
  7.6.1 Company Profile
  7.6.2 Sales (Million $) Sales growth rate
  7.6.3 Contact Information
7.7 Novo Nordisk
  7.7.1 Company Profile
  7.7.2 Sales (Million $) Sales growth rate
  7.7.3 Contact Information
7.8 Novartis
  7.8.1 Company Profile
  7.8.2 Sales (Million $) Sales growth rate
  7.8.3 Contact Information
7.9 Merck
  7.9.1 Company Profile
  7.9.2 Sales (Million $) Sales growth rate
  7.9.3 Contact Information
7.10 Lilly
  7.10.1 Company Profile
  7.10.2 Sales (Million $) Sales growth rate
  7.10.3 Contact Information
7.11 3sbio
  7.11.1 Company Profile
  7.11.2 Sales (Million $) Sales growth rate
  7.11.3 Contact Information
7.12 Changchun High and New Technology Industry (Group) Inc
  7.12.1 Company Profile
  7.12.2 Sales (Million $) Sales growth rate
  7.12.3 Contact Information
7.13 CP Guojian Pharmacy
  7.13.1 Company Profile
  7.13.2 Sales (Million $) Sales growth rate
  7.13.3 Contact Information
7.14 Biotech Pharma
  7.1.1 Company Profile
  7.14.2 Sales (Million $) Sales growth rate
  7.14.3 Contact Information
7.15 Gelgen Biopharma
  7.15.1 Company Profile
  7.15.2 Sales (Million $) Sales growth rate
  7.15.3 Contact Information
Biosimilar
7.1 SANDOZ (NOVARTIS)
  7.1.1 Company Profile
  7.1.2 Sales (Million $) Sales growth rate
  7.1.3 Contact Information
7.2 Teva Pharmaceutical Industries
  7.2.1 Company Profile
  7.2.2 Sales (Million $) Sales growth rate
  7.2.3 Contact Information
7.3 Hospira （Pfizer）
  7.3.1 Company Profile
  7.3.2 Sales (Million $) Sales growth rate
  7.1.3 Contact Information
7.4 MYLAN INC
  7.4.1 Company Profile
  7.4.2 Sales (Million $) Sales growth rate
  7.4.3 Contact Information
7.5 3sbio
  7.5.1 Company Profile
  7.5.2 Sales (Million $) Sales growth rate
  7.5.3 Contact Information
7.6 Changchun High and New Technology Industry (Group) Inc
  7.6.1 Company Profile
  7.6.2 Sales (Million $) Sales growth rate
  7.6.3 Contact Information
7.7 CP Guojian Pharmacy
  7.7.1 Company Profile
  7.7.2 Sales (Million $) Sales growth rate
  7.7.3 Contact Information
7.8 Biotech Pharma
  7.8.1 Company Profile
  7.8.2 Sales (Million $) Sales growth rate
  7.8.3 Contact Information
7.9 Gelgen Biopharma
  7.9.1 Company Profile
  7.9.2 Sales (Million $) Sales growth rate
  7.9.3 Contact Information

CHAPTER EIGHT BIOLOGICS AND BIOSIMILARS INDUSTRY CHAIN STRUCTURE ANALYSIS

8.1 Biologics Segment Market Analyses
8.2 Biologics and Biosimilars Industry Development in Emerging Markets
8.3 Key Applications and Consumption Analysis
8.4 Key Regions and Consumption Analysis

CHAPTER NINE BIOLOGICS AND BIOSIMILARS MARKETING CHANNELS ANALYSIS

9.1 Biologics and Biosimilars Marketing Channels Status
9.2 Biologics and Biosimilars Marketing Channels Characteristic
9.3 Biologics and Biosimilars Marketing Channels Development Trend

CHAPTER TEN 2015E-2021 BIOLOGICS AND BIOSIMILARS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

10.1 2015E-2021 Biologics Market Status and Forecast
10.2 2015E-2021 Biosimilars Market Status and Forecast

CHAPTER ELEVEN PACLITAXEL INDUSTRY DEVELOPMENT PROPOSALS

11.1 Macroeconomic Development Countermeasures
  11.1.1 Specific control measures
  11.1.2 Key success factors between Mature Countries and Emerging Countries
  11.1.3 Macroeconomic policy
11.2 New Firms Enter Market Strategy
11.3 New Project Investment Proposals
11.4 Competitive Environment Strategy Proposals

CHAPTER TWELVE BIOLOGICS AND BIOSIMILARS NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS

12.1 Biologics and Biosimilars Project SWOT Analysis
12.2 Biologics and Biosimilars Project PEST Analysis
  12.2.1 Political Factors
  12.2.2 Economic Factors
  12.2.3 Sociocultural Factors
  12.2.4 Technological Factors

CHAPTER THIRTEEN GLOBAL BIOLOGICS AND BIOSIMILARS INDUSTRY RESEARCH CONCLUSIONS

Tables & Figures

TABLES AND FIGURES

Figure Biologics and Biosimilars Product Picture
Figure Biologics Product Picture
Figure Biosimilars Product Picture
Table Difference between biologics and biosimilar:
Table Biosimilars Classification and Application List
Figure Biologics and Biosimilars Industry Chain Structure
Figure 2014 Global FOB Policy and Regulations
Table Global Major Generic Companies Active in FOB Development List
Table 2012-2016 Patent Expirations Brand in US, Japan, UK, France and Germany
Figure 2014 Global Major Manufacturers Biologics Sales Market Share
Figure 2014 Global Major Manufacturers Biosimilars Sales Market Share
Figure 2014 Global Major Countries Biologics Sales Market Share
Figure 2014 Global Major Countries Biosimilars Sales Market Share
Figure 2015-2020 Global Biologics Sales and Growth Rate
Figure 2015-2020 Global Biosimilars Sales and Growth Rate
Figure 2010-2014 China Number of New Drugs Approved
Figure Innovation Fund Invested on Biologics Industry Trend
Figure 2014 China Major Manufacturers Biologics Sales Market Share
Figure 2014 China Major Manufacturers Biosimilars Sales Market Share
Table 2010-2015E Global Key Manufacturers Biologics Proportion of Revenues List
Table 2010-2015E Global Key Manufacturers Biosimilars Proportion of Revenues List
Table 2013 Global Top Ten Biosimilars Products Sales (billion USD) List
Table Biological Medicines with Patents about to expire or expire List
Table Difference of Specifications between Original Chemical Drugs and Biologics List
Table Difference of Specifications among Original Biologics, Biosimilars and Chemical Generics List
Figure Biologics and Biosimilars Marketing Process
Figure 2014 Biologics and Biosimilars Cost Structure List
Table 2010-2015E Global Major Manufacturers Biologics Sales and Total Sales List
Table 2010-2015E Global Major Manufacturers Biologics Sales Market Share List
Figure 2010 Global Major Manufacturers Biologics Sales Market Share
Figure 2011 Global Major Manufacturers Biologics Sales Market Share
Figure 2012 Global Major Manufacturers Biologics Sales Market Share
Figure 2013 Global Major Manufacturers Biologics Sales Market Share
Figure 2014 Global Major Manufacturers Biologics Sales Market Share
Table 2010-2015E China Major Manufacturers Biologics Sales and Total Sales List
Table 2010-2015E China Major Manufacturers Biologics Sales and Total Sales Market Share List
Figure 2010 China Major Manufacturers Biologics Sales Market Share
Figure 2011 China Major Manufacturers Biologics Sales Market Share
Figure 2012 China Major Manufacturers Biologics Sales Market Share
Figure 2013 China Major Manufacturers Biologics Sales Market Share
Figure 2014 China Major Manufacturers Biologics Sales Market Share
Table 2010-2015E Global Major Manufacturers Biosimilars Sales and Total Sales List
Table 2010-2015E Global Major Manufacturers Biosimilars Sales Market Share List
Figure 2010 Global Major Manufacturers Biosimilars Sales Market Share
Figure 2011 Global Major Manufacturers Biosimilars Sales Market Share
Figure 2012 Global Major Manufacturers Biosimilars Sales Market Share
Figure 2013 Global Major Manufacturers Biosimilars Sales Market Share
Figure 2014 Global Major Manufacturers Biosimilars Sales Market Share
Table 2010-2015E China Major Manufacturers Biosimilars Sales and Total Sales List
Table 2010-2015E China Major Manufacturers Biosimilars Sales and Total Sales Market Share List
Figure 2010 China Major Manufacturers Biosimilars Sales Market Share
Figure 2011 China Major Manufacturers Biosimilars Sales Market Share
Figure 2012 China Major Manufacturers Biosimilars Sales Market Share
Figure 2013 China Major Manufacturers Biosimilars Sales Market Share
Figure 2014 China Major Manufacturers Biosimilars Sales Market Share
Table 2010-2015E Pfizer Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Pfizer Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Pfizer Biologics Sales (Million $) and Global Market Share
Table 2010-2015E Roche Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Roche Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Roche Biologics Sales (Million $) and Global Market Share
Table 2010-2015E Amgen Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Amgen Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Amgen Biologics Sales (Million $) and Global Market Share
Table 2010-2015E AbbVie Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E AbbVie Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E AbbVie Biologics Sales (Million $) and Global Market Share
Table 2010-2015E Sanofi Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Sanofi Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Sanofi Biologics Sales (Million $) and Global Market Share
Table 2010-2015E Johnson & Johnson Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Johnson & Johnson Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Johnson & Johnson Biologics Sales (Million $) and Global Market Share
Table 2010-2015E Novo Nordisk Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Novo Nordisk Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Novo Nordisk Biologics Sales (Million $) and Global Market Share
Table 2010-2015E Novartis Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Novartis Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Novartis Biologics Sales (Million $) and Global Market Share
Table 2010-2015E Merck Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Merck Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Merck Biologics Sales (Million $) and Global Market Share
Table 2010-2015E Lilly Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Lilly Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Lilly Biologics Sales (Million $) and Global Market Share
Table 2010-2015E 3sbio Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E 3sbio Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E 3sbio Biologics Sales (Million $) and Global Market Share
Table 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biologics Sales (Million $) and Growth Rate
Figure 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biologics Sales (Million $) and Growth Rate
Figure 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biologics Sales (Million $) and Global Market Share
Table 2010-2015 CP Guojian Pharmacy Biologics Sales (Million $) and Growth Rate
Figure 2010-2015 CP Guojian Pharmacy Biologics Sales (Million $) and Growth Rate
Figure 2010-2015 CP Guojian Pharmacy Biologics Sales (Million $) and Global Market Share
Table 2010-2015 Biotech Pharma Biologics Sales (Million $) and Growth Rate
Figure 2010-2015 Biotech Pharma Biologics Sales (Million $) and Growth Rate
Figure 2010-2015 Biotech Pharma Biologics Sales (Million $) and Global Market Share
Table 2010-2015E Gelgen Biopharma Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Gelgen Biopharma Biologics Sales (Million $) and Growth Rate
Figure 2010-2015E Gelgen Biopharma Biologics Sales (Million $) and Global Market Share
Table 2010-2015 SANDOZ (NOVARTIS) Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 SANDOZ (NOVARTIS) Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 SANDOZ (NOVARTIS) Biosimilar Sales (Million $) and Global Market Share
Table 2010-2015 Teva Pharmaceutical Industries Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 Teva Pharmaceutical Industries Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 Teva Pharmaceutical Industries Biosimilar Sales (Million $) and Global Market Share
Table 2010-2015 Pfizer Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 Pfizer Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 Pfizer Biosimilar Sales (Million $) and Global Market Share
Table 2010-2015 MYLAN INC. Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 MYLAN INC. Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 MYLAN INC. Biosimilar Sales (Million $) and Global Market Share
Table 2010-2015E 3sbio Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015E 3sbio Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015E 3sbio Biosimilar Sales (Million $) and Global Market Share
Table 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 Changchun High and New Technology Industry (Group) Inc. Biosimilar Sales (Million $) and Global Market Share
Table 2010-2015 CP Guojian Pharmacy Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 CP Guojian Pharmacy Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 CP Guojian Pharmacy Biosimilar Sales (Million $) and Global Market Share
Table 2010-2015 Biotech Pharma Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 Biotech Pharma Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015 Biotech Pharma Biosimilar Sales (Million $) and Global Market Share
Table 2010-2015E Gelgen Biopharma Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015E Gelgen Biopharma Biosimilar Sales (Million $) and Growth Rate
Figure 2010-2015E Gelgen Biopharma Biosimilar Sales (Million $) and Global Market Share
Figure Biologics Global Market Share and Share of Biologics by Sales
Figure Spending on Biologics in Emerging Markets
Figure Recombinant Protein Production in Emerging Markets
Table 2014 China Infective Population of Several Diseases
Figure 2014 Global Biologics in Research Statistics by Indications
Figure the biologics with more than 1Bn USD by country
Figure Data exclusivity period
Figure 2014 Global Biologics Consumption Market Share by Regions
Figure 2014 Global Biosimilars Consumption Market Share by Regions
Table 2003, 2008 and 2013 Global Pharmaceutical Market Scale Ranking
Figure Beset sales biologics patent
Figure Biologics and Biosimilars Domestic Marketing Channels Status
Figure Imported Biologics and Biosimilars Marketing Channels Status
Figure 4 P’ S Marketing model
Figure 7 P’ S Marketing model
Table 2015E-2021 Global Biologics Sales (Million $) and Growth Rate
Figure 2015E-2021 Global Biologics Sales and Growth Rate
Table 2015E-2021 China Biologics Sales (Million $) and Growth Rate
Figure 2015E-2021 China Biologics Sales and Growth Rate
Table 2015E-2021 Global Biosimilars Sales (Million $) and Growth Rate
Figure 2015E-2021 Global Biosimilars Sales and Growth Rate
Table 2015E-2021 China Biosimilars Sales (Million $) and Growth Rate
Figure 2015E-2021 China Biosimilars Sales and Growth Rate
Figure Health and Care Industry market trend in China
Figure characteristics that influence the background of Health and Care Industry market in China
Table factors vary according to the level of economic development
Table New Firms Enter Market Strategy
Figure administration on start up
Figure Share of GDP according to the size of the companies
Table New Project Investment Proposals
Figure European private equity funds raised in 2010
Table Competitive Environment Strategy Proposals
Table Biologics and Biosimilars New Project SWOT Analysis for Chinese Company
Figure 2007-2013 China GDP (100 million RMB) and Growth Rate
Figure 2007-2013 China CPI Change Trend
Figure 2007-2013 China Urban and Rural Incomes (RMB)
Figure 2007-2013 China Total Retail Sales of Consumer Goods (100 million RMB) and Growth Rate
Figure 2007-2013 China Investment in Fixed Assets (100 million RMB) and Growth Rate
Figure 2007-2013 China the Total Value of Imports and Exports of Goods (100 million USD) and Growth Rate
Table 2014 China Macroeconomic Forecast Key Indicators (%)
Figure 2007-2013 EU27 GDP Growth Rate
Figure 2007-2013 EU27 HICP Index (The month of year-on-year)
Figure 2007-2013 United States GDP (100 million USD)
Figure 2007-2013 United States CPI
Figure 2007-2013 Japan GDP (Billion Yen)
Figure 2007-2013 Japan CPI (The month of year-on-year)
Figure 1993-2013 Global Incidences of Malignant Tumors
Figure the amount of biosimilar in research